IRIS
MATERA, Maria Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.141
NA - Nord America 9.050
AS - Asia 8.222
SA - Sud America 1.506
AF - Africa 100
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 11
Totale 37.043
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 11.389
US - Stati Uniti d'America 8.917
SG - Singapore 3.249
IE - Irlanda 1.959
CN - Cina 1.577
HK - Hong Kong 1.522
BR - Brasile 1.284
UA - Ucraina 1.122
GB - Regno Unito 893
IT - Italia 884
VN - Vietnam 848
DE - Germania 755
FI - Finlandia 289
KR - Corea 273
FR - Francia 262
GR - Grecia 223
SE - Svezia 191
TR - Turchia 185
IN - India 183
JP - Giappone 93
AR - Argentina 77
MX - Messico 50
BD - Bangladesh 49
CA - Canada 43
ID - Indonesia 43
IQ - Iraq 38
EC - Ecuador 34
NL - Olanda 31
CO - Colombia 26
BE - Belgio 25
ZA - Sudafrica 23
CL - Cile 22
ES - Italia 21
UZ - Uzbekistan 20
PK - Pakistan 19
VE - Venezuela 19
MA - Marocco 18
PY - Paraguay 18
AT - Austria 17
PE - Perù 17
PL - Polonia 15
DZ - Algeria 13
IL - Israele 13
MY - Malesia 12
MD - Moldavia 11
EG - Egitto 10
TW - Taiwan 10
AE - Emirati Arabi Uniti 8
AU - Australia 8
EU - Europa 8
IR - Iran 8
SA - Arabia Saudita 8
TH - Thailandia 8
TN - Tunisia 8
BG - Bulgaria 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
JM - Giamaica 7
KE - Kenya 7
AL - Albania 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
HN - Honduras 6
NP - Nepal 6
PH - Filippine 6
BB - Barbados 5
CI - Costa d'Avorio 5
LB - Libano 5
AZ - Azerbaigian 4
NI - Nicaragua 4
OM - Oman 4
PT - Portogallo 4
UY - Uruguay 4
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
JO - Giordania 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AP - ???statistics.table.value.countryCode.AP??? 2
EE - Estonia 2
GE - Georgia 2
GY - Guiana 2
HR - Croazia 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SC - Seychelles 2
SN - Senegal 2
TM - Turkmenistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 37.020
Salva come PNG Salva come JPEG
Città #
Moscow 4.002
Dublin 1.955
Jacksonville 1.716
Hong Kong 1.506
Santa Clara 1.356
Singapore 1.322
San Jose 994
Chandler 756
Ashburn 403
Princeton 359
Medford 326
Ho Chi Minh City 275
Seoul 257
Bremen 225
Hefei 211
Hanoi 203
Roxbury 188
Boardman 183
Beijing 163
San Mateo 158
The Dalles 149
Bengaluru 139
Wilmington 139
Ann Arbor 102
Woodbridge 86
Cambridge 77
Dallas 74
São Paulo 72
Des Moines 71
Naples 67
Da Nang 59
New York 58
Düsseldorf 49
Caserta 42
Haiphong 42
Los Angeles 41
Rio de Janeiro 38
Orem 36
Rome 36
Shanghai 35
Munich 34
Norwalk 34
Jinan 33
Nanjing 25
Brussels 23
Curitiba 23
Hải Dương 23
Biên Hòa 22
Guangzhou 22
Brasília 21
Milan 21
Tashkent 20
Falkenstein 19
Memphis 19
Zhengzhou 19
Belo Horizonte 18
Changsha 18
Guarulhos 18
Hebei 18
Napoli 18
Nuremberg 17
Campinas 16
Houston 16
Mountain View 16
Porto Alegre 16
San Potito Sannitico 16
Shenyang 16
Redwood City 15
Salvador 15
San Marcellino 15
Turku 15
Dhaka 14
Frankfurt am Main 14
Mexico City 14
Baghdad 13
Bari 13
Council Bluffs 13
Goiânia 13
London 13
Osasco 13
Shenzhen 13
Atlanta 12
Auburn Hills 12
Brooklyn 12
Haikou 12
Montreal 12
Phoenix 12
Amsterdam 11
Bắc Ninh 11
Canoas 11
Dearborn 11
Guayaquil 11
Hangzhou 11
Lima 11
Ninh Bình 11
Sorocaba 11
Tokyo 11
Caxias do Sul 10
Florence 10
Manaus 10
Totale 18.936
Salva come PNG Salva come JPEG
Nome #
Farmaci dell’Apparato Respiratorio: Regolazione del tono broncomotore. 398
Sistema purinergico. 362
“COPDCoRi: applicazione non invasiva per la stima e la previsione del rischio di patologia coronarica nei pazienti affetti da broncopneumopatia cronica ostruttiva (BPCO)”. 181
Effects of chronic administration of β-blockers on airway responsiveness in a murine model of heart failure. 179
Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa 177
Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling. 172
Aclidinium bromide inhalation powder for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema 172
10. Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease. 170
Amminoacidi eccitatori e regolazione centrale della funzione cardiovascolare: contributi sperimentali. 165
Brain natriuretic peptide : much more than a biomarker 162
ACE2: The Major Cell Entry Receptor for SARS-CoV-2 162
Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter? 154
A comparison of sensory nerve function in human, guinea-pig, rabbit and marmoset airways 151
Effect of hyperbaric oxygen therapy in experimental subcutaneous and pulmonary infections due to Pseudomonas aeruginosa 151
1. New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol. 150
A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD 147
Calcium dependence of the evoked arginine vasopressin release by electrical stimulation and by L-glutamate 146
Acute effects of higher than customary doses of salmeterol and salbutamol in patients with acute exacerbation of COPD. 145
Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders 144
Assessing the viability of long-acting β(2)-agonists in paediatric asthma patients: a pharmacokinetic/pharmacodynamic perspective. 144
A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease 141
Characterization of adenosine receptors involved in adenosine-induced bronchoconstriction in allergic rabbits 141
A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease 140
Aclidinium bromide for the treatment of chronic obstructive pulmonary disease. 140
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma 136
Animal models of chronic obstructive pulmonary disease and their role in drug discovery and development: a critical review 136
5-HT modifiers as a potential treatment of asthma 135
Farmaci del sistema cardiovascolare, del sangue e del rene 135
Protein Prenylation Contributes to the Effects of LPS on EFS-Induced Responses in Human Isolated Bronchi 134
Excitatory amino acids and cardiovascular apparatus: experimental studies on conscious rats with L-glutamate, N-methyl-D-aspartate, kainate and quisqualate 133
Effects of hyperbaric oxygen exposure on non-adrenergic non-cholinergic responses of rat trachea 133
A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease 133
A review of the pharmacokinetics of M3 muscarinic receptor antagonists used for the treatment of asthma 133
[The therapeutic prospects of ischemic cardiopathy] 131
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD 130
The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement 130
Contribution of sensory nerves to LPS-induced hyperresponsiveness of human isolated bronchi. 129
. Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells. 129
K+ channels and guinea-pig trachea: a possible functional modulation by GABAB receptors 128
Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis 127
Research on heterocyclic compounds. XIV - Imidazothiazole and imidazobenzothiazole derivatives: synthesis and antiinflammatory activity 125
Role of 5-hydroxytryptamine in mediating adenosine-induced airway contraction 125
Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients. 124
A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD 124
N-acetylcysteine in COPD may be beneficial, but for whom? 123
Effects of RO 5-4864 and PK 11195 on guinea pig trachea 122
Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways. 121
Ions and intracellular mechanisms involved in the effects of L-glutamate on arginine vasopressin release: in vitro researches on rat neurohypophysis 121
Effects of in vitro 5-HT1 receptor activation in guinea pig trachea 121
Evidence of muscarinic receptor subtypes in airway smooth muscle of normal volunteers and of chronic obstructive pulmonary disease patients 121
Flomoxef, a new oxacephem antibiotic, does not cause hemostatic defects 121
A potential role of triple therapy for asthma patients 121
Bioavailability of timolol and aceclidine after ocular instillation in the rabbit 119
N-Acetylcysteine protects human bronchi by modulating the release of neurokinin A in an ex vivo model of COPD exacerbation. 119
Immune checkpoint inhibitors: a new landscape for extensive stage small cell lung cancer treatment 119
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application 118
A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study 118
The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study 117
Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease. 117
Prenatal and postnatal vanadium exposure in rats: effect on vasomotor reactivity development of pups 117
Brain Natriuretic Peptide Protects Against Hyperreactivity of Human Asthmatic Airway Smooth Muscle via an Epithelial Cell Dependent Mechanism. 116
Prenatal and postnatal antimony exposure in rats: effect on vasomotor reactivity development of pups 116
Functional role of nitric oxide in guinea pig tracheal epithelium 115
Intraulmonary penetration of antimicrobials and implications in the treatment of lower respiratory tract infections. 115
Treatment of COPD: moving beyond the lungs. 115
Treating systemic effects of COPD. 114
Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma. 114
Adding a LAMA to ICS/LABA therapy: a meta-analysis of triple therapy in COPD 114
characterization of the Pharmacological interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi. 113
Terapie per i disordini labirintici: effetti e riflessi sulla pressione arteriosa 113
Evidence for non-adrenergic non-cholinergic contractile responses in bovine and swine trachea 113
Farmaci per il trattamento delle aritmie cardiache. 112
Advances in the Pharmacological Management of Pediatric Acute Respiratory Distress Syndrome 112
Farmaci per il trattamento della cardiopatia ischemica. 111
The burden of obesity in asthma and COPD: Role of adiponectin 111
Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease 110
Translational Study Searching for Synergy between Glycopyrronium and Indacaterol. 110
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis 110
Pharmacological treatment and current controversies in COPD 109
Tremor and β(2)-adrenergic agents: is it a real clinical problem? 109
I farmaci del sistema nervoso centrale 109
Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update 109
Possible functional modulation by acetylcholine of nitric oxide on guinea pig isolated trachea 108
Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents 107
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024? 106
Pharmacological Characterization of Adenosine Receptors on Isolated Human Bronchi 106
Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease. 106
Role of 5-HT2 receptor subtypes in mediating adenosine-induced airway contraction 106
Bronchodilator response to formoterol Turbuhaler in patients with COPD under regular treatment with formoterol Turbuhaler 106
Nitric oxide regulatory role in sensitized guinea pig trachea 106
Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis 106
Impact of biologics on lung hyperinflation in patients with severe asthma 105
Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children 105
Theophylline in the inhibition of angiotensin-converting enzyme inhibitor-induced cough 105
Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation 105
A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome 104
Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease. A multiple-dose study 104
Addition of an extra dose of salmeterol Diskus to conventional dose of salmeterol Diskus in patients with COPD 104
Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patients 104
Serum digoxin levels after concomitant ticarcillin and clavulanic acid administration 103
Totale 13.085
Salva come PNG Salva come JPEG
Categoria #
all - tutte 133.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.590
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 0 0 62
2021/20221.935 168 15 27 42 688 7 25 47 59 70 185 602
2022/20233.445 411 47 36 234 440 248 7 178 1.694 17 53 80
2023/20241.395 103 34 35 138 551 59 36 33 14 21 85 286
2024/20255.490 34 33 57 154 874 615 551 446 657 1.411 394 264
2025/202619.233 848 800 1.035 1.260 1.277 10.682 1.152 704 772 368 234 101
Totale 37.435